mci-196 has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Mizobuchi, M; Sanada, D | 1 |
| Dimkovic, N; Kostic, S; Locatelli, F; Manning, A; Nakajima, S; Pljesa, S; Pontoriero, G; Sano, H; Spasovski, G | 1 |
1 review(s) available for mci-196 and Kidney Diseases
| Article | Year |
|---|---|
[Novel phosphate binders under development].
Topics: Bile Acids and Salts; Chronic Disease; Citric Acid; Clinical Trials as Topic; Drug Design; Ferrous Compounds; Humans; Hyperphosphatemia; Kidney Diseases; Polyamines; Risk Factors; Sevelamer | 2009 |
1 trial(s) available for mci-196 and Kidney Diseases
| Article | Year |
|---|---|
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphorus; Renal Dialysis; Young Adult | 2010 |